2026-08176RuleWallet

FDA Weed Meds Get Federal Green Light: Faster Permits for Businesses

Published Date: 4/28/2026

Rule

Summary

Starting April 28, 2026, FDA-approved marijuana-based medicines move from the strictest drug category (Schedule I) to a less strict one (Schedule III). This change helps medical marijuana businesses get faster federal permits to make and sell these products legally. If you have a state medical marijuana license, you’ll find it easier and quicker to work with these medicines under new federal rules.

Free Policy Watch

New rules are filed every week. Most people never see them.

Pick a topic. PRIA watches every federal rule and tells you when one hits your household.

Pick a topic to get started

Analyzed Economic Effects

7 provisions identified: 3 benefits, 4 costs, 0 mixed.

Section 280E Deduction Disallowance Ends for Licensees

As a result of the rescheduling, state medical marijuana licensees will no longer be subject to the deduction disallowance in Internal Revenue Code Section 280E, which applies only to businesses trafficking in Schedule I or II substances. The rule notes businesses should consult tax counsel and that the rule itself does not make a federal tax‑liability determination.

FDA‑approved Marijuana Moved to Schedule III

Effective April 28, 2026, drug products containing marijuana that have been approved by the Food and Drug Administration and marijuana covered by a state medical marijuana license are placed in Schedule III of the Controlled Substances Act. This change applies specifically to marijuana as defined in the CSA when included in an FDA‑approved drug product or when subject to a state medical marijuana license.

Expedited Federal Registration for State Licensees

The rule creates an expedited DEA registration pathway for entities holding state medical marijuana licenses so they can manufacture, distribute, or dispense under federal law; applicants who apply within 60 days of publication must be processed within six months, and early applicants may lawfully operate under their state-issued licenses while DEA reviews their application. A DEA registration will automatically suspend if the underlying state license is suspended, revoked, or expires.

DEA Registration, Compliance, And Fees Required

Anyone handling FDA‑approved drug products containing marijuana must obtain DEA registration for Schedule III activities and comply with inventory, recordkeeping, security, labeling, disposal, and reporting rules. Except for government employees, applicants must pay registration fees: Manufacturers $3,699 annually; Distributors $1,850 annually; Dispensers (including pharmacies) $888 for a registration valid for 3 years.

Unlicensed Bulk Marijuana Still Schedule I

Marijuana that is not in an FDA‑approved drug product and not subject to a state medical marijuana license (including unlicensed bulk marijuana, marijuana extract, and Delta‑9‑THC material used to make FDA‑approved products) remains a Schedule I controlled substance and continues to be subject to quota requirements and DEA purchase/wholesale‑monopoly procedures.

Import/Export Permits Remain Required

The rule adds FDA‑approved drug products containing marijuana and state‑licensed medical marijuana to the list of nonnarcotic Schedule III–V substances that require a DEA import or export permit under 21 CFR 1312.30. Importations and exportations of these covered products will be permitted only pursuant to a permit.

Prescription Requirement for Dispensing

Prescriptions are required before dispensing FDA‑approved drug products containing marijuana except when the product is dispensed directly by a DEA‑registered practitioner (e.g., physician, dentist, hospital). Prescriptions must include the drug name, strength, dosage form, quantity, directions for use, and be issued for a legitimate medical purpose.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Rule Effective
4/28/2026
4/28/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in